We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SUPN market cap is 1.69B. The company's latest EPS is USD 0.0240 and P/E is 1285.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 177.35M | 167.84M | 155.41M | 134.77M | 154.34M |
| Operating Income | -1.52M | 32.44M | 5.18M | -17.59M | 8.14M |
| Net Income | 1.75M | 25.48M | 16.95M | -831k | -15.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 392.76M | 520.4M | 586.31M | 667.75M | 609.04M |
| Operating Income | 148.57M | 173.7M | 86.03M | 46.12M | -5.27M |
| Net Income | 113.06M | 126.95M | 53.42M | 60.71M | 1.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.69B | 1.7B | 1.79B | 1.29B | 1.29B |
| Total Liabilities | 840.33M | 816.3M | 879.66M | 373.19M | 372.97M |
| Total Equity | 852.8M | 886.2M | 912.15M | 919.91M | 912.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.16B | 1.5B | 1.69B | 1.7B | 1.28B |
| Total Liabilities | 564.85M | 759.24M | 873.3M | 816.3M | 356.16M |
| Total Equity | 595.43M | 744.86M | 815.85M | 886.2M | 921.52M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 89.26M | 116.83M | 49.13M | 30.25M | 66.13M |
| Investing | -167.9M | -216.66M | 239.78M | 300.08M | 334.71M |
| Financing | -13.31M | -10.48M | 80.17M | -398.74M | -398.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 143.13M | 138.4M | 127.13M | 116.83M | 111.09M |
| Investing | -157.92M | -34.7M | -81.91M | -216.66M | 268.73M |
| Financing | 3.93M | 3.56M | -130.42M | -10.48M | -397.88M |
| Market Cap | 1.69B |
| Price to Earnings Ratio | 1285.00 |
| Price to Sales Ratio | 2.77 |
| Price to Cash Ratio | 22.49 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | - |
| Shares Outstanding | 54.73M |
| Average Volume (1 week) | 339.66k |
| Average Volume (1 Month) | 356.1k |
| 52 Week Change | -17.37% |
| 52 Week High | 38.09 |
| 52 Week Low | 21.99 |
| Spread (Intraday) | 23.57 (56.11%) |
| Company Name | Supernus Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.supernus.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
